Catch up on the latest in #cardiology by heading over to our cardiology resource center. hcplive.com/clinical/cardi…

Positive topline data from SEQUOIA-HCM announced by Cytokinetics, with statistically significant benefit on exercise capacity and in all 10 prespecified secondary endpoints. Learn more: hcplive.com/view/cytokinet… #Cardiomyopathy #Cardiotwitter

New research links maternal T1D to nearly all subtypes of congenital #heart defects, while overweight was associated only with certain defect types. hcplive.com/view/maternal-… #Cardiotwitter

Earlier this week, we spoke with Dr. Deepak L. Bhatt, of Mount Sinai Fuster Heart Hospital, about a recent publication in European Society of Cardiology Journals highlighting the need for greater in-hospital initiation and uptitration of GDMT in #HeartFailure. hcplive.com/view/deepak-bh…

For American Heart Month, we asked 9 experts in cardiology for their perspective on the most prevalent issues facing the specialty today. hcplive.com/view/experts-p… #Cardiology #CardiovascularDisease Dr. Deepak L. Bhatt Dr. Laxmi Mehta @HCPLiveCardiology HCPLive

To commemorate the conclusion of #BlackHistoryMonth, HCPLive conducted a series of interviews with experts in diversity and equity in healthcare to address medicine's elephant in the room: how lacking clinical trial diversity impacts real-world care: hcplive.com/view/experts-p…

How does SELECT change management of CV risk? In the latest #DiabetesDialogue special guest A. Michael Lincoff, MD joins Diana Isaacs, PharmD, BC-ADM, CDCES and Natalie Bellini to discuss SELECT, its implications, and the future of incretin therapies. hcplive.com/view/diabetes-… #Obesity #Diabetes #Cardiology

What are the top issues facing cardiology in 2024? DCRI's Steve Greene joins other leading experts to provide insights into key challenges and what can be done to overcome them: hcplive.com/view/experts-p…

Last week, HFSA published a scientific statement on cognitive impairment in #HeartFailure. I was lucky enough to sit in on a conversation between lead co-authors (Eiran Gorodeski, MD, MPH/Parag Goyal MD MSc) and HFSA president James Fang. Clip below, link in next tweet for full video:

The FDA has approved the first oral antihypertensive agent with a new mechanism of action in more 30 years with the approval of aprocitentan (Tryvio; Idorsia Pharmaceuticals Ltd) for difficult-to-control hypertension. Learn more: hcplive.com/view/fda-appro… #FDANews #Hypertension

🚨 We are 10 days away from our pre-ACC Tweet Chat with APAC! 🚨 Join us on April 1 at 8 PM ET for a 10-question tweet chat discussing all things #ACC24, including the most anticipated sessions, pressing research needs, and more! hcplive.com/view/hcplive-a… #Cardiology

🚨 We are 1 week away from our pre-ACC Tweet Chat with Academy of Physician Associates In Cardiology 🚨 Check back later this week for the full list of questions or tune in on April 1 from 8 to 9 PM ET to participate! hcplive.com/view/hcplive-a… #CardioTwitter #ACC24 #ACC2024

ACC.24 Tweet Chat on Monday from 8-9 PM from HCPLive and APAC!! Questions list posted tomorrow on: hcplive.com/view/hcplive-a… #Cardiology #Cardiotwitter #ACC24

Tune in Monday Night!

🚨 We are just days away from our #PreACCChat with APAC on April 1 from 8-9 PM ET ! 🚨 Check out our 10 questions and posting times to prepare for the evening and participate on Monday night! #CardioTwitter #Cardiology #ACC24 Part 1:

Part 2 of the Question List:

🚨🚨 #PreAccChat with APAC at 8 PM! 🚨🚨 Live Tweet using #PreACCchat or schedule them out using the questions list provided below! #Cardiology #Cardiotwitter

At #ACC24, I sat down with the meeting's Young Investigator Award winner @SafChat to discuss her analysis of PARADIGM-HF and 2024 KDIGO Risk Classifications. Learn more: hcplive.com/view/safia-cha… Muthu Vaduganathan Brendon Neuen scottdavidsolomon #HeartFailure #HFrEF ACC Media Center

The HCPLive Cardiology April 2024 month in review spotlights #FDANews in cardiology and top updates from #ACC24. Learn more: hcplive.com/view/cardiolog…

Updated AHA/ACC guidelines for hypertrophic cardiomyopathy include a new emphasis on the roles of exercise and cardiac myosin inhibitors. Learn more: hcplive.com/view/new-cardi… #Cardiology #Cardiomyopathy